234 related articles for article (PubMed ID: 2273963)
21. Biocompatibility of various dialyzer membranes. The effects of the dialyzer membranes on the lymphocyte subpopulation during hemodialysis.
Miyazawa S; Morita T; Osaki K; Uemura S; Nakashima A; Harada R; Otsuji Y; Hashimoto S
Fukuoka Igaku Zasshi; 1986 Jul; 77(7):366-72. PubMed ID: 3770646
[No Abstract] [Full Text] [Related]
22. Intradialytic body weight changes and dialyzer pore size as main contributing factors to the evolution of beta-2-microglobulin in dialysis.
Vanholder RC; Ringoir SM
Blood Purif; 1990; 8(1):32-44. PubMed ID: 2198890
[TBL] [Abstract][Full Text] [Related]
23. Thrombocytopenia associated with use of a biocompatible hemodialysis membrane: a case report.
Post JB
Am J Kidney Dis; 2010 Jun; 55(6):e25-8. PubMed ID: 20110145
[TBL] [Abstract][Full Text] [Related]
24. Lower prevalence of depression in hemodialysis patients who use polysulfone dialyzers.
Hsu HJ; Chen CK; Wu MS
Am J Nephrol; 2009; 29(6):592-7. PubMed ID: 19145074
[TBL] [Abstract][Full Text] [Related]
25. The influence of cuprophan and polysulfone membranes on dialyzer reusability and intradialytic complications.
Kadiri S; Kehinde Z; Arije A; Salako BL
Afr J Med Med Sci; 2001 Sep; 30(3):191-4. PubMed ID: 14510127
[TBL] [Abstract][Full Text] [Related]
26. Inflammatory response of a new synthetic dialyzer membrane. A randomised cross-over comparison between polysulfone and helixone.
Stefoni S; Colì L; Cianciolo G; Donati G; Ruggeri G; Ramazzotti E; Pohlmeier R; Lang D
Int J Artif Organs; 2003 Jan; 26(1):26-32. PubMed ID: 12602466
[TBL] [Abstract][Full Text] [Related]
27. Biocompatibility of heparin-grafted hemodialysis membranes: impact on monocyte chemoattractant protein-1 circulating level and oxidative status.
Morena M; Jaussent I; Chalabi L; Bargnoux AS; Dupuy AM; Badiou S; Rakic C; Thomas M; Canaud B; Cristol JP; Michel F
Hemodial Int; 2010 Oct; 14(4):403-10. PubMed ID: 20955273
[TBL] [Abstract][Full Text] [Related]
28. [Comparison of biocompatibility of hemophane, cellulose diacetate and acrilonitile membranes in hemodialysis].
Germin Petrović D
Acta Med Croatica; 2004; 58(1):31-6. PubMed ID: 15125391
[TBL] [Abstract][Full Text] [Related]
29. Hemodialysis leukopenia and complement function with different dialyzers.
Amadori A; Candi P; Sasdelli M; Massai G; Favilla S; Passaleva A; Ricci M
Kidney Int; 1983 Dec; 24(6):775-81. PubMed ID: 6562280
[TBL] [Abstract][Full Text] [Related]
30. [Experience with the multiple use of dialyzers].
Strokov AG; Poz IaL; Baeva LB; Levitskiĭ ER; Annenkov AE; Rud'ko IA; Kubatiev AA
Ter Arkh; 1994; 66(6):60-5. PubMed ID: 7940372
[TBL] [Abstract][Full Text] [Related]
31. Biocompatibility of hemodialysis membranes: evaluation in an ovine model.
Burhop KE; Johnson RJ; Simpson J; Chenoweth DE; Borgia J
J Lab Clin Med; 1993 Feb; 121(2):276-93. PubMed ID: 8433041
[TBL] [Abstract][Full Text] [Related]
32. Use of electron-beam sterilized hemodialysis membranes and risk of thrombocytopenia.
Kiaii M; Djurdjev O; Farah M; Levin A; Jung B; MacRae J
JAMA; 2011 Oct; 306(15):1679-87. PubMed ID: 22009100
[TBL] [Abstract][Full Text] [Related]
33. Improvement of dialyzer compatibility by reduction of membrane surface area.
Schaefer RM; Rautenberg W; Neumann S; Heidland A; Hörl WH
Clin Nephrol; 1986; 26 Suppl 1():S35-8. PubMed ID: 3644705
[TBL] [Abstract][Full Text] [Related]
34. Effect of dialyzer geometry on granulocyte and complement activation.
Schaefer RM; Heidland A; Hörl WH
Am J Nephrol; 1987; 7(2):121-6. PubMed ID: 3496792
[TBL] [Abstract][Full Text] [Related]
35. Dialyzer clearances and mass transfer-area coefficients for small solutes at low dialysate flow rates.
Leypoldt JK; Kamerath CD; Gilson JF; Friederichs G
ASAIO J; 2006; 52(4):404-9. PubMed ID: 16883120
[TBL] [Abstract][Full Text] [Related]
36. [C-reactive protein (CRP) as a marker of of hemodialysis biocompatibility].
Szepietowski T; Krajewska M
Polim Med; 1997; 27(1-2):47-59. PubMed ID: 9380601
[TBL] [Abstract][Full Text] [Related]
37. Biocompatibility and permeability of dialyzer membranes do not affect anemia, erythropoietin dosage or mortality in japanese patients on chronic non-reuse hemodialysis: a prospective cohort study from the J-DOPPS II study.
Yokoyama H; Kawaguchi T; Wada T; Takahashi Y; Higashi T; Yamazaki S; Fukuhara S; Akiba T; Akizawa T; Asano Y; Kurokawa K; Saito A;
Nephron Clin Pract; 2008; 109(2):c100-8. PubMed ID: 18596379
[TBL] [Abstract][Full Text] [Related]
38. [Reprocessing of capillary dialyzers].
Stetsiuk EA; Iarmolinskiĭ IS; Ponomareva VIu; Makhlin NV
Urol Nefrol (Mosk); 1989; (1):55-9. PubMed ID: 2718285
[TBL] [Abstract][Full Text] [Related]
39. [The evaluation of hemodialysis adequacy during the use of different dialysis membranes].
Stasević Z; Subarić-Gorgieva G; Krcmarević J; Stolić R; Trajković G
Srp Arh Celok Lek; 2007; 135(1-2):48-53. PubMed ID: 17503568
[TBL] [Abstract][Full Text] [Related]
40. Biocompatibility and performance of a modified cellulosic and a synthetic high flux dialyzer. A randomized crossover comparison between cellulose triacetate and polysulphon.
Grooteman MP; Nubé MJ; van Limbeek J; van Houte AJ; Daha MR; van Geelen JA
ASAIO J; 1995; 41(2):215-20. PubMed ID: 7640431
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
